Forward Pharma Operations ApS: Financial statements 2019
CVR: 38757504
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Forward Pharma Operations ApS (CVR 38757504) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 326,709 and a net result of DKK -7,546,712 compared with DKK -15,791,179 the year before. That is an increase of 210.2% compared with the year before. The profit margin was -2,309.9%. Equity in the 2019 report amounted to DKK 324,701,255. The solvency ratio was 93.7%.
- Revenue
- DKK 326,709
- Gross Profit
- DKK -11,250,606
- Profit/Loss
- DKK -7,546,712
- Equity
- DKK 324,701,255
- Total Assets
- DKK 346,717,150
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 327 t. | -11.3 mio. | -7.5 mio. | 324.7 mio. | - |
| 2018 | 105 t. | -27.1 mio. | -15.8 mio. | 332.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Forward Pharma Operations ApS has published its annual report for 2018. Revenue came to DKK 105,339, and the net result was DKK -15,791,179.
About Forward Pharma Operations ApS
Forward Pharma Operations ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 30 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported revenue of DKK 99,127 and a net result of DKK -68,343,758 compared with DKK 1,043,207 the year before. Equity in the 2024 report amounted to DKK 280,041,147.